About AlgoNomics
AlgoNomics’ vision is to employ its advanced proprietary platform in structural bioinformatics tools to develop rationally designed therapeutics in the broad field of immunotherapy.
AlgoNomics offers in silico support to companies that develop rationally designed vaccines and therapeutic proteins.
AlgoNomics owns a rich, proprietary platform for structure-based protein and peptide design. The technology platform contains biologically validated, innovative tools, which have been developed in-house. These tools add great value in target characterization and lead optimization.
- Focus : Manufacturer
- Industry : Pharma
Product portfolio of AlgoNomics
News about AlgoNomics
Here you will find AlgoNomics NV
See the theme worlds for related content
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.
